ArticleThe lancet. HIV2022

Dolutegravir dosing for children with HIV weighing less than 20 kg: pharmacokinetic and safety substudies nested in the open-label, multicentre, randomised, non-inferiority ODYSSEY trial.

Hylke Waalewijn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.